A trial of simeprevir and sofosbuvir combination with or without ribavirin in patients with decompensated cirrosis induced by hepatitis C genotype 1

Trial Profile

A trial of simeprevir and sofosbuvir combination with or without ribavirin in patients with decompensated cirrosis induced by hepatitis C genotype 1

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Sep 2015

At a glance

  • Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
  • Indications Liver cirrhosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 09 Sep 2015 New trial record
    • 11 Nov 2014 Interim results presented at the 65th Annual Meeting of the American Association for the Study of Liver Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top